FDA Import Refusal AEK-0444538-1/11/1 — Apitoria Pharma Private Limited
The FDA refused shipment AEK-0444538-1/11/1 from Apitoria Pharma Private Limited (India) on February 17, 2022. The refused product falls under Drugs and Biologics — PIOGLITAZONE HCL. Cited charges: 3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- February 17, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY62 PIOGLITAZONE HCL
- Charges
- 3280,75